LOW-VOLUME · MALE-LED
degarelix Side Effects
degarelix (also sold as Firmagon) is a LOW-VOLUME FAERS extract #394 of 524 by FAERS report count. Still opens on MALE-LED: 1% of sex-coded reports are female (26 F / 3,558 M).
Data updated 2026-05-15
- 4,979
- FAERS reports
Thinner FAERS book - still a temporal association ledger, not proof of cause. Methodology.
degarelix reporting skew - 1% of sex-coded reports are female (26 F / 3,558 M). Volume band LOW-VOLUME #394 of 524 by FAERS report count; caseload SIGNAL.
Thinner FAERS extract for degarelix (Firmagon) (4,979 reports #394 of 524 by FAERS report count). 1% of sex-coded reports are female (26 F / 3,558 M). Sparse books still carry named reaction rows when present; not medical advice.
Counts from the openFDA FAERS extract (2007–2025). Stamps SIGNAL · DEATH-HEAVY · HOSP-HEAVY · MALE-LED.
FATIGUE leads 377 of 4,979 reports
MALE-LED reporters · age peak 75+
Male-led reporters (99% of sex-coded rows)
Age peak 75+ (1,199 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death-mentioned subset is HEAVY here (576 reports, 11.6%). Top co-reported reactions in that subset - voluntary, not causal.
| Reaction | Reports |
|---|---|
| DEATH | 190 |
| DISEASE PROGRESSION | 97 |
| PROSTATE CANCER | 39 |
| MALIGNANT NEOPLASM PROGRESSION | 33 |
| PROSTATE CANCER METASTATIC | 28 |
| ASTHENIA | 23 |
| FATIGUE | 21 |
| GENERAL PHYSICAL HEALTH DETERIORATION | 19 |
| PNEUMONIA | 19 |
| MYOCARDIAL INFARCTION | 17 |
| CARDIAC ARREST | 16 |
| DYSPNOEA | 16 |
| FALL | 16 |
| PAIN | 15 |
| ANAEMIA | 14 |
| DECREASED APPETITE | 14 |
| PROSTATIC SPECIFIC ANTIGEN INCREASED | 14 |
| PYREXIA | 12 |
| CEREBROVASCULAR ACCIDENT | 11 |
Reactions in Hospitalization Reports
Hospitalization is HEAVY (1,629, 32.7% of the book). Top reactions in those rows:
| Reaction | Reports |
|---|---|
| FATIGUE | 109 |
| FALL | 98 |
| PYREXIA | 93 |
| ASTHENIA | 69 |
| ANAEMIA | 62 |
| ACUTE KIDNEY INJURY | 57 |
| DYSPNOEA | 57 |
| INJECTION SITE PAIN | 56 |
| CEREBROVASCULAR ACCIDENT | 55 |
| DEHYDRATION | 55 |
| MALAISE | 55 |
| ABDOMINAL PAIN | 54 |
| PAIN | 54 |
| URINARY TRACT INFECTION | 53 |
| DEATH | 49 |
| DIZZINESS | 49 |
| DIARRHOEA | 48 |
| DECREASED APPETITE | 47 |
| INJECTION SITE ERYTHEMA | 47 |
| GENERAL PHYSICAL HEALTH DETERIORATION | 44 |
How to read degarelix FAERS figures (SIGNAL · DEATH-HEAVY · HOSP-HEAVY)
FAERS holds 4,979 voluntary reports linked to degarelix (Firmagon), 2007-2025. Death is listed on 576 (11.6%). Hospitalization appears on 1,629 (32.7%). Top co-reported indication: Prostate Cancer.
Sparse extract - named reactions and MALE-LED skew still differ by drug; not a complete safety profile.
Read with degarelix
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-HEAVY stamps.
ABS(total_reports) peer at 5,119 FAERS cases (Δ 140 heavier vs degarelix); DEATH-HEAVY · HOSP-MID · SEX-BALANCED vs this page's SIGNAL · DEATH-HEAVY · HOSP-HEAVY · MALE-LED.
ABS(total_reports) peer at 4,779 FAERS cases (Δ 200 lighter vs degarelix); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's SIGNAL · DEATH-HEAVY · HOSP-HEAVY · MALE-LED.
ABS(total_reports) peer at 5,207 FAERS cases (Δ 228 heavier vs degarelix); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's SIGNAL · DEATH-HEAVY · HOSP-HEAVY · MALE-LED.
ABS(total_reports) peer at 5,225 FAERS cases (Δ 246 heavier vs degarelix); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's SIGNAL · DEATH-HEAVY · HOSP-HEAVY · MALE-LED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 50.5 pp vs degarelix's DEATH-HEAVY): CASELOAD · HOSP-MID.
degarelix stamps DEATH-HEAVY · HOSP-HEAVY; FAERS outcome shares are signal-detection rates, not incidence. Read them next to caseload SIGNAL and the label guide.